JILLIAN PHILLIPS: Open Payments
NPI 1306308598 · BLOOMINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 11 payments from 8 companies in 2025. Trend: 2023 $135 · 2024 $144 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $79 |
| PFIZER INC. | 1 | $29 |
| Lilly USA, LLC | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Medtronic, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Tris Pharma Inc | 1 | $17 |
Products named: Ozempic, TRUMENBA, MOUNJARO, Wegovy, UBRELVY, Auvelity, INTELLIS ADAPTIVESTIM, SHINGRIX.
Industry payments across IL — which companies pay providers there.
